Today, Cigna Ventures (CV), the corporate venture fund of global health service company Cigna, announced that it’s leading a $23M Series D round of funding in GNS Healthcare (GNS), a highly specialized AI company that turns millions of data streams into personalized insights that precisely match the appropriate clinical care/treatment intervention to the right patient at the right time.Cigna joins other leading carriers and health plans and GNS investors, including Cambia Health Solutions, Echo
Read More
Impact of Precision Medicine| News, Policy, Analysis, Insights - HIT Consultant
Can AI Transform Patient Care from Reactive Craft to Strategic Art?
Personalized Analytics is becoming essential in healthcare, stemming from the movement from fee-for-service to a value-based market. The need to preempt and prevent disease on a more personal level, rather than merely reacting to symptoms, has created a significant opportunity for machine learning-based applications. This “analytics of one” approach (using advanced mathematical models and artificial intelligence techniques) is already impacting several key areas:
1. Medical imaging is utilizing
Read More
Konica Minolta, Novo Nordisk, Philips, Stryker Join Emory Healthcare Innovation Hub
The Emory Healthcare Innovation Hub today announced Konica Minolta Healthcare, Novo Nordisk, Philips, and Stryker as its newest strategic partners committed to improving patient care and provider experience by using health IT to solve the most pressing problems facing healthcare.Demand-Driven InnovationFounded in 2018, the Emory Healthcare Innovation Hub is a healthcare innovation and commercialization program bringing together all the pieces of the healthcare innovation continuum to validate
Read More
Is Artificial Intelligence The Answer To A Plethora of Healthcare Problems?
The world of healthcare is changing, and with it, our approach to understanding the concept of patients and doctors, ways of delivering care, and building a better relationship between every member associated with it is also changing. Like other industries, healthcare is also going through a major revolution, and Artificial Intelligence (AI) stands at the core of it.
Biological sciences and medical research are rapidly changing fields. Each day, we witness advances in genomics, imaging, and
Read More
Mount Sinai Launches Center for Artificial Intelligence and Human Health
The Icahn School of Medicine at Mount Sinai today announced the launch of a new center dedicated to advancing the delivery of health care through research, development, and implementation of innovative artificial intelligence tools and technologies. The Hamilton and Amabel James Center for Artificial Intelligence and Human Health in Manhattan to combine artificial intelligence with data science and genomics in a standalone site. The building will enable researchers to enhance their
Read More
Tempus, Leidos Biomedical Research Inc. Launch Effort to Enhance The Cancer Genome Atlas
Tempus, a technology company advancing precision medicine through the collection and analysis of molecular and clinical data at scale announced today that it was selected by Leidos Biomedical Research Inc. (Leidos Biomed) to abstract and structure follow-up clinical data for The Cancer Genome Atlas (TCGA) Project for submission to the National Cancer Institute’s Genomic Data Commons (GDC).The Cancer Genome Atlas (TCGA) Project BackgroundThere are 230 distinct investigators that contributed
Read More
Mothers in the U.S. Are Dying: What Are We Doing to Save Them?
The maternal mortality rate in the United States is the highest of any developed country – and the rate is rising. The US is currently the most dangerous place to give birth in the developed world.
Few to none of these maternal deaths are due to medical mismanagement. Instead, problems of access, care coordination, and inequities in health care resources and social services are at the heart of maternal death rates.
Minority women, particularly those facing socioeconomic challenges, are the
Read More
Data-Driven Precision Medicine Startup Tempus Lands $200M to Expand Into New Therapeutic Areas
Tempus, a leading technology company advancing precision medicine through the collection and analysis of molecular and clinical data, announced today an additional $200M financing at a value of $3.1 billion dollars. The investors include Baillie Gifford, Franklin Templeton, NEA, Novo Holdings, Revolution Growth, and funds and accounts managed by T. Rowe Price. With this latest round, the company has raised $520 million since its founding in September 2015.Founded in 2015, Tempus has the largest
Read More
Healthcare M&A Survey: Health IT Represents the Richest Opportunity in Sector
Most healthcare mergers and acquisitions (M&A) professionals see a positive outlook for healthcare and life sciences deals next year, even as political uncertainty will be the biggest factor to upend transactions, according to a recent Merrill Insight poll of global M&A professionals.According to the poll, which included more than 200 respondents from the Americas and Europe, the Middle East and Africa (EMEA), 52% of respondents believe that the M&A market is headed in a positive
Read More
Top 5 Roadblocks to Population Health Management Adoption for Providers
The healthcare system is undergoing a transformation to restore the patient to the center of their care and to provide all patients with the highest quality care at the lowest possible price and with the best possible experience. Frequently the patient’s health journey is fragmented between multiple providers, an issue which must be addressed as a key part of any successful value-based care model.
Population health management (PHM) is an umbrella term that incorporates the multitude of payment
Read More
